Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04587128
Title Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Wisconsin, Madison
Indications

colorectal cancer

Therapies

Cetuximab

Cetuximab + Irinotecan

Panitumumab

Irinotecan + Panitumumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST